Two fresh ways to play the weight loss and megacap tech hype
A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. Source
Read MoreA major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks. Source
Read MoreChart analyst Todd Gordon breaks down the best plays in small caps. Source link
Read MoreWhile weight loss drugmakers are catching a bid with investors, experts are less certain that ETFs linked to the category
Read MoreThe most important stocks in the QQQ fund have changed over different market cycles. Source link
Read MoreNow's a time for value rather than growth, and for stock-picking instead of passive management, says Brian Szytel, The Bahnsen
Read MoreThe Toronto Stock Exchange’s parent company acquired ETF education company VettaFi. According to CEO John McKenzie, it will help with
Read MoreStocks in midsize companies tend to outperform their larger and smaller counterparts over time. Three have outperformed Nvidia over the
Read MoreTwo market experts tackle investors' renewed appetite toward intermediate-term Treasury bonds. Source link
Read MoreOver two thousand attendees are descending on the Fontainebleau Hotel in Miami Beach for the annual Exchange ETF conference Source
Read More